BROADWOOD CAPITAL INC
CIK 1278387 · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$839.84M
Companies
9
Total Filings
74
Lifetime Open-Market Net
$101.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 12,685,041 | $3.20 | $40.59M | $75.10M | 7 | 2026-04-27 |
| STAA | 10%+ Owner | 26,526,474 | $28.37 | $752.56M | $62.94M | 37 | 2025-04-07 |
| LCTX | 10%+ Owner | 68,730,970 | $1.27 | $87.29M | $4.03M | 2 | 2022-03-25 |
| BTX | 10%+ Owner | — | $9.03 | — | $0 | 2 | 2017-09-13 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | 10%+ Owner | 27,182,162 | — | — | $46.04M | 10 | 2017-02-17 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 1,282,050 | — | — | $0 | 1 | 2015-02-11 | |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 3,636,496 | — | — | -$92.74M | 4 | 2014-08-06 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,617,246 | — | — | $3.75M | 3 | 2012-06-28 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 3,051,668 | — | — | $2.35M | 7 | 2008-04-29 |
Recent Filings · Page 5 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-08-15 | BTX | Other (J) | — | $0 | EDGAR |
| 2014-08-06 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Gift (G) | −685,236 | $0 | EDGAR |
| 2014-02-26 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Sell (S) | −250,800 | -$19.96M | EDGAR |
| 2014-02-20 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Sell (S) | −919,200 | -$68.88M | EDGAR |
| 2014-01-27 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Sell (S) | −60,000 | -$3.90M | EDGAR |
| 2013-12-30 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +900,126 | $3.16M | EDGAR |
| 2013-07-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-29 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +600,000 | $2.29M | EDGAR |
| 2012-11-19 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +1,034,484 | $3.00M | EDGAR |
| 2012-06-28 | PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | Buy (P) | +246,300 | $1.99M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.